SpyGlass Pharma

PharmaceuticalsSeries DAliso Viejo, USspyglasspharma.com

Latest round

Series D

Last raised

May 2025

Total raised

$115M

Investors

7

About SpyGlass Pharma

Based in California, US, and established in 2019, SpyGlass Pharma, Inc. provides therapies for the treatment of chronic ophthalmic diseases. The company was co-founded by Malik Y. Kahook and Glenn Sussman. As of 2023, the company is headed by its CEO Patrick Mooney. In February 2026, SpyGlass Pharma, Inc.4 million shares at USD 16 per share on Nasdaq under the ticker symbol "SGP". The company offers SpyGlass Drug Delivery Platform which is a controlled-release drug delivery platform for all cataract surgeons, that consists of a single-piece, hydrophobic acrylic IOL and two drug-eluting pads. It is implanted along with the SpyGlass IOL into the capsular bag through a standard cataract surgical technique.

Who invested in SpyGlass Pharma

7 investors across 2 rounds

See all investors in SpyGlass Pharma

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    May 30, 2025

    Amount

    $75M

    Investors

    Locked

  2. Series C

    Jul 6, 2023

    Amount

    $40M

    Investors

    Locked

Questions about SpyGlass Pharma

Who invested in SpyGlass Pharma?

SpyGlass Pharma has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has SpyGlass Pharma raised?

SpyGlass Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did SpyGlass Pharma last raise money?

SpyGlass Pharma's most recent round on record is a Series D, in May 2025.

What does SpyGlass Pharma do?

Based in California, US, and established in 2019, SpyGlass Pharma, Inc.

Where is SpyGlass Pharma headquartered?

SpyGlass Pharma is headquartered in Aliso Viejo, US.

Which VCs invest in companies like SpyGlass Pharma?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at SpyGlass Pharma's stage. Their profiles are linked below.

Raising like SpyGlass Pharma? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.